Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.
Stocktwits on MSN
Cathie Wood loads up on TEM, ILMN and biotech stocks but pares stake in this pharma giant that had a blowout Q3
ARK's actively managed ETFs made a mix of moves, trimming some established holdings while adding to smaller healthcare names. ・ARK Genomic Revolution ETF increased its exposure to Tempus AI, Pacific ...
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results